Clinical Compendium

A summary of peer-reviewed publications with Restrata.

The body of published clinical data on Restrata continues to grow.

Since 2018, Acera Surgical products have been the subject of 28 peer-reviewed publications and counting that reinforce the healing power of Restrata. See the chart below for information on each publication.

A New Standard in Clinical Results

Average Closure Rate

Average Weeks to Closure^a

Average Number of Applications

Chronic Wounds

DFUs

82%

8.3

5.4^b

VLUs

89%

10.2

5.9^b

Limb Salvage

86%

14.7

1.8

Acute Wounds

Surgical

96%

4.6^c

1.7

Chronic Wounds

DFUs

Average Closure Rate

82%

Average Weeks to Closure^a

8.3

Average Number of Applications

5.4^b

VLUs

Average Closure Rate

89%

Average Weeks to Closure^a

10.2

Average Number of Applications

5.9^b

Limb Salvage

Average Closure Rate

86%

Average Weeks to Closure^a

14.7

Average Number of Applications

1.8

Acute Wounds

Surgical

Average Closure Rate

96%

Average Weeks to Closure^a

4.6^c

Average Number of Applications

1.7

a) Chronic wounds to closure, surgical wounds to re-granulation or skin graft application

Chronic Wounds Include: Diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), transmetatarsal amputations (TMAs), partial ray amputations, Lisfranc amputations, pressure ulcers (PUs), neuropathic ulcers, dehisced surgical wounds, and non-healing traumatic wounds

b) Two studies did not report average number of applications for DFU patients. One study did not report average number of applications for VLU patients.

Acute Wounds Include: Necrotizing soft-tissue infection (NSTI) resections, skin cancer resections, traumatic wounds, calciphylaxis, sarcoma resections, post-Mohs wounds, hematomas, and flap donor sites

c) Analyzed in studies in which granulation was reported

Summary of Select Publications
Select a disease state below for the list of publications

Chronic Wounds

Acute Wounds

DFUs

VLUs

Limb Salvage

Other Chronic Wounds

Trauma

General

Plastics

Oncology

Head & Neck

Pre-Clinical and Mechanism of Action

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} A prospective, blinded, randomized controlled clinical trial evaluating the effect of the synthetic electrospun fiber matrix in the treatment of chronic diabetic foot ulcers¹	Author(s) Husain K, et al.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 19	Summary of Outcomes 74% complete wound closure in Restrata per -protocol group; 33% complete wound closure in the control per-protocol group	Level of Evidence I
Title ^{Click to view full publications} Evaluation of wound healing of diabetic foot ulcers in a prospective clinical trial using a synthetic hybrid-scale fiber matrix²	Author(s) Abicht BP, et al.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 24	Summary of Outcomes 75% complete wound closure	Level of Evidence II
Title ^{Click to view full publications} Implantable nanomedical scaffold facilitates healing of chronic lower extremity wounds³	Author(s) Regulski MJ, MacEwan MR.	Journal Wounds	Restrata-Treated Wounds 82	Summary of Outcomes 85% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Treatment of complex lower extremity wounds utilizing synthetic hybrid-scale fiber matrix⁴	Author(s) Husain K, et al.	Journal JAPMA	Restrata-Treated Wounds 23	Summary of Outcomes 96% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Lower extremity wounds treated with a synthetic hybrid-scale fiber matrix⁵	Author(s) Barton EC, Abicht BP.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 23	Summary of Outcomes 96% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Utility of synthetic electrospun fiber matrix in general surgery: From head to toe²⁷	Author(s) Hagen SS	Journal Surgery	Restrata-Treated Wounds 22	Summary of Outcomes 89.5% reach clinical goals	Level of Evidence III
Title ^{Click to view full publications} Utility of synthetic hybrid-scale fiber matrix in complex lower extremity wounds: A case series⁶	Author(s) Benson B.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 10	Summary of Outcomes 100% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Impact of a novel synthetic nanofibre matrix to treat hard-to-heal wounds⁷	Author(s) Herron K.	Journal Journal of Wound Care	Restrata-Treated Wounds 5	Summary of Outcomes Complete closure, decrease in wound area, stimulation of granulation tissue	Level of Evidence III
Title ^{Click to view full publications} The Use of a Synthetic Hybrid-Scale Fiber Matrix to Treat Difficult-to-Heal Wounds⁸	Author(s) Wilson M.	Journal Cureus	Restrata-Treated Wounds 6	Summary of Outcomes 67% complete wound closure	Level of Evidence III

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Implantable nanomedical scaffold facilitates healing of chronic lower extremity wounds³	Author(s) Regulski MJ, MacEwan MR.	Journal Wounds	Restrata-Treated Wounds 82	Summary of Outcomes 85% wound closure	Level of Evidence III
Title ^{Click to view full publications} Synthetic Hybrid-Scale Fiber Matrix for the Treatment of Complex Lower-Extremity Wounds⁴	Author(s) Husain K, et al.	Journal JAPMA	Restrata-Treated Wounds 23	Summary of Outcomes 96% wound closure	Level of Evidence III
Title ^{Click to view full publications} Lower extremity wounds treated with a synthetic hybrid-scale fiber matrix⁵	Author(s) Barton EC, Abicht BP.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 23	Summary of Outcomes 96% wound closure	Level of Evidence III
Title ^{Click to view full publications} Utility of synthetic electrospun fiber matrix in general surgery: From head to toe²⁷	Author(s) Hagen SS	Journal Surgery	Restrata-Treated Wounds 22	Summary of Outcomes 89.5% reach clinical goals	Level of Evidence III
Title ^{Click to view full publications} Impact of a novel synthetic nanofibre matrix to treat hard-to-heal wounds⁵	Author(s) Herron K.	Journal Journal of Wound Care	Restrata-Treated Wounds 5	Summary of Outcomes Complete closure, decrease in wound area, stimulation of granulation tissue	Level of Evidence III
Title ^{Click to view full publications} The Use of a Synthetic Hybrid-Scale Fiber Matrix to Treat Difficult-to-Heal Wounds⁸	Author(s) Wilson M.	Journal Cureus	Restrata-Treated Wounds 6	Summary of Outcomes 67% complete wound closure	Level of Evidence III

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Lower extremity wounds treated with a synthetic hybrid-scale fiber matrix⁵	Author(s) Barton EC, Abicht BP.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 23	Summary of Outcomes 96% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Utility of synthetic hybrid-scale fiber matrix in complex lower extremity wounds: A case series⁶	Author(s) Benson B.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 10	Summary of Outcomes 100% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Clinical Evaluation of a Synthetic Hybrid-Scale Matrix in the Treatment of Lower Extremity Surgical Wounds⁹	Author(s) Tucker D.	Journal Cureus	Restrata-Treated Wounds 9	Summary of Outcomes 78% complete closure	Level of Evidence III
Title ^{Click to view full publications} The Use of a Synthetic Hybrid-Scale Fiber Matrix to Treat Difficult-to-Heal Wounds⁸	Author(s) Wilson M.	Journal Cureus	Restrata-Treated Wounds 6	Summary of Outcomes 67% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Application of abductor digiti minimi muscle flap and synthetic electrospun fiber matrix after resection of osteomyelitis of fifth meatarsal: A two-patient case report²⁸	Author(s) Patel S	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 2	Summary of Outcomes 100 % wound closure	Level of Evidence V

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Utility of synthetic electrospun fiber matrix in general surgery: From head to toe²⁷	Author(s) Hagen SS	Journal Surgery	Restrata-Treated Wounds 22	Summary of Outcomes 89.5% reach clinical goals	Level of Evidence III
Title ^{Click to view full publications} Implantable Nanomedical Scaffold Facilitates Healing of Chronic Lower Extremity Wounds³	Author(s) Regulski MJ, MacEwan MR.	Journal Wounds	Restrata-Treated Wounds 82	Summary of Outcomes 85% wound closure	Level of Evidence III
Title ^{Click to view full publications} Utility of synthetic electrospun fiber matrix in general surgery: From head to toe²⁷	Author(s) Hagen SS	Journal Surgery	Restrata-Treated Wounds 22	Summary of Outcomes 89.5% reach clinical goals	Level of Evidence III
Title ^{Click to view full publications} Lower extremity wounds treated with a synthetic hybrid-scale fiber matrix⁵	Author(s) Barton EC, Abicht BP.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 23	Summary of Outcomes 96% wound closure	Level of Evidence III
Title ^{Click to view full publications} Utility of synthetic hybrid-scale fiber matrix in complex lower extremity wounds: A case series⁶	Author(s) Benson B.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 10	Summary of Outcomes 100% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Impact of a novel synthetic nanofibre matrix to treat hard-to-heal wounds⁷	Author(s) Herron K.	Journal Journal of Wound Care	Restrata-Treated Wounds 5	Summary of Outcomes Complete closure, decrease in wound area, stimulation of granulation tissue	Level of Evidence III
Title ^{Click to view full publications} Fully Synthetic Bioengineered Nanomedical Scaffold in Chronic Neuropathic Foot Ulcers¹⁰	Author(s) Killeen AL, et al.	Journal Wounds	Restrata-Treated Wounds 4	Summary of Outcomes Stimulated granulation tissue while preventing necrosis	Level of Evidence III
Title ^{Click to view full publications} Use of a synthetic hybrid-scale fiber matrix in the management of chronic and complex wounds: A retrospective case series¹¹	Author(s) Price T.	Journal Wounds	Restrata-Treated Wounds 28	Summary of Outcomes 89% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} The Use of a Synthetic Hybrid-Scale Fiber Matrix to Treat Difficult-to-Heal Wounds⁸	Author(s) Wilson M.	Journal Cureus	Restrata-Treated Wounds 6	Summary of Outcomes 67% complete wound closure	Level of Evidence III
Title ^{Click to view full publications} Management of irradiated post-mastectomy wound dehiscence with synthetic electrospun fiber matrix: A case report¹²	Author(s) Montminy T, Oppenheimer N, Cocco D.	Journal Frontiers in Oncology	Restrata-Treated Wounds 1	Summary of Outcomes 100% complete wound closure	Level of Evidence V
Title ^{Click to view full publications} Histopathologic Analysis of a Recalcitrant Calcaneal Wound Treated Using a Synthetic Hybrid-scale Fiber Matrix¹³	Author(s) Harder JG, MacKay, BJ, et al.	Journal Plastic and Reconstructive Surgery Global Open	Restrata-Treated Wounds 1	Summary of Outcomes Successful granulation tissue formation, histological assessment	Level of Evidence V
Title ^{Click to view full publications} Treatment of a Complex Pressure Ulcer Using a Synthetic Hybrid-Scale Fiber Matrix¹⁴	Author(s) Herron K.	Journal Cureus	Restrata-Treated Wounds 1	Summary of Outcomes Significant healing	Level of Evidence V

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Utility of synthetic electrospun fiber matrix in general surgery: From head to toe²⁷	Author(s) Hagen SS	Journal Surgery	Restrata-Treated Wounds 22	Summary of Outcomes 89.5% reach clinical goals	Level of Evidence III
Title ^{Click to view full publications} Synthetic hybrid-scale fiber matrix in the trauma and acute care surgical practice¹⁶	Author(s) Fernandez LG, et al.	Journal Wounds	Restrata-Treated Wounds 3	Summary of Outcomes Significant reepithelialization and wound healing	Level of Evidence V
Title ^{Click to view full publications} Treatment of Hematomas Using a Synthetic Hybrid-Scale Fiber Matrix¹⁸	Author(s) Temple EW.	Journal Cureus	Restrata-Treated Wounds 2	Summary of Outcomes 100% complete closure	Level of Evidence V
Title ^{Click to view full publications} Treatment of a Complex Pressure Ulcer Using a Synthetic Hybrid-Scale Fiber Matrix¹⁵	Author(s) Fernandez LG, et al.	Journal Wounds	Restrata-Treated Wounds 1	Summary of Outcomes Successfully promoted granulation tissue for STSG application	Level of Evidence V
Title ^{Click to view full publications} Treatment of traumatic crush injury using a synthetic hybrid-scale fiber matrix in conjunction with split-thickness skin graft¹⁷	Author(s) Martini CJ, et al.	Journal Foot & Ankle Surgery: Techniques, Reports & Cases	Restrata-Treated Wounds 1	Summary of Outcomes Stimulated granulation tissue for STSG application	Level of Evidence V
Title ^{Click to view full publications} Management of irradiated post-mastectomy wound dehiscence with synthetic electrospun fiber matrix: A case report¹²	Author(s) Montminy T, Oppenheimer N, Cocco D.	Journal Frontiers in Oncology	Restrata-Treated Wounds 1	Summary of Outcomes 100% complete wound closure	Level of Evidence V
Title ^{Click to view full publications} A Synthetic Hybrid-scale Fiber Matrix for Complex Surgical Wounds: Consensus Guidelines¹⁹	Author(s) Fernandez LG, et al.	Journal Wounds	Restrata-Treated Wounds N/A (consensus guidelines)	Summary of Outcomes Overview of clinical use scenarios and recommendations	Level of Evidence V

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Utility of synthetic electrospun fiber matrix in general surgery: From head to toe²⁷	Author(s) Hagen SS	Journal Surgery	Restrata-Treated Wounds 22	Summary of Outcomes 89.5% reach clinical goals	Level of Evidence III

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Utility of a Synthetic Hybrid-Scale Fiber Matrix in Surgical Soft Tissue Reconstruction²⁰	Author(s) Chowdhry S.	Journal ePlasty	Restrata-Treated Wounds 22	Summary of Outcomes 100% wound closure. Demonstrated efficacy encouraging granulation tissue for healing by secondary intent, STSG or flap.	Level of Evidence III
Title ^{Click to view full publications} Reconstruction of Post-Mohs Surgical Wounds Using a Novel Nanofiber Matrix²³	Author(s) McGowan J.	Journal Wounds	Restrata-Treated Wounds 4	Summary of Outcomes 100% complete closure	Level of Evidence III
Title ^{Click to view full publications} Utility of synthetic hybrid-scale fiber matrix in dermatologic wounds²⁴	Author(s) Zaiac M, et al.	Journal JAAD Case Reports	Restrata-Treated Wounds 2	Summary of Outcomes 100% complete wound closure	Level of Evidence V

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Wound Healing Outcomes Following Treatment With Synthetic Hybrid-Scale Fiber Matrix After Resection of Soft Tissue Tumors or Infections²¹	Author(s) Lindeque B, Moon D.	Journal Wounds	Restrata-Treated Wounds 10	Summary of Outcomes 70% wound closure. Improving graft incorporation via supporting healthy granulation tissue formation or closed via secondary intent. 30% lost to follow-up.	Level of Evidence III

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} Applications of Synthetic Hybrid-Scale Fiber Matrix in Head and Neck Reconstruction: A Case Series²²	Author(s) Horwich P, et al.	Journal Case Reports in Oncology	Restrata-Treated Wounds 13	Summary of Outcomes 100% wound closure	Level of Evidence III

Title ^{Click to view full publications}	Author(s)	Journal	Restrata-Treated Wounds	Summary of Outcomes	Level of Evidence
Title ^{Click to view full publications} What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold²⁵	Author(s) MacEwan, M, et al.	Journal Cureus	Restrata-Treated Wounds N/A (mechanism of action)	Summary of Outcomes N/A (mechanism of action)	Level of Evidence N/A (mechanism of action)
Title ^{Click to view full publications} Comparison of a Fully Synthetic Electrospun Matrix to a Bi-Layered Xenograft in Healing Full Thickness Cutaneous Wounds in a Porcine Model²⁶	Author(s) MacEwan, M, et al.	Journal Cureus	Restrata-Treated Wounds 6 (6 xenograft treated wounds)	Summary of Outcomes Increased collagen maturation, granulation tissue, and epitelialization at day 15 in the Restrata group	Level of Evidence N/A

References

1) Husain K, Malik A, Kirchens J, Choi G. A Prospective, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of the Synthetic Electropsun Fiber Matrix in the Treatment of Chronic Diabetic Foot Ulcers. Foot & Ankle Surgery: Techniques, Reports & Cases. Published online January 1, 2024:100362-100362. doi:https://doi.org/10.1016/j.fastrc.2024.100362‌

2) Abicht BP, Deitrick GA, MacEwan MR, Jeng L. Evaluation of wound healing of diabetic foot ulcers in a prospective clinical trial using a synthetic hybrid-scale fiber matrix. Foot & Ankle Surgery: Techniques, Reports & Cases. 2022;2(1):100135. doi:10.1016/j.fastrc.2021.100135

3) Regulski MJ, MacEwan MR. Implantable Nanomedical Scaffold Facilitates Healing of Chronic Lower Extremity Wounds. Wounds. 2018;30(8):E77-E80.

4) Husain K, Malik A, Kirchens J. Synthetic Hybrid-Scale Fiber Matrix for the Treatment of Complex Lower-Extremity Wounds. J Am Podiatr Med Assoc. 2023;113(1):21-071. doi:10.7547/21-071

5) Barton EC, Abicht BP. Lower extremity wounds treated with a synthetic hybrid-scale fiber matrix. Foot & Ankle Surgery: Techniques, Reports & Cases. 2021;1(3):100076. doi:10.1016/j.fastrc.2021.100076

6) Benson B. Utility of synthetic hybrid-scale fiber matrix in complex lower extremity wounds: A case series. Foot &amp; Ankle Surgery: Techniques, Reports &amp; Cases. 2023;3(3): 100317. doi:10.1016/j.fastrc.2023.100317

7) Herron K. Impact of a novel synthetic nanofibre matrix to treat hard-to-heal wounds. Journal of Wound Care. 2022;31(11):962-968. doi:10.12968/jowc.2022.31.11.962

8) Wilson M. The Use of a Synthetic Hybrid-Scale Fiber Matrix to Treat Difficult-to-Heal Wounds. Cureus. 2023;15(12):e50405. Published 2023 Dec 12. doi:10.7759/cureus.50405

9) Tucker D. Clinical evaluation of a synthetic hybrid-scale matrix in the treatment of lower extremity surgical wounds. Cureus. July 2022. doi:10.7759/cureus.27452

10) Killeen AL, Brock KM, Loya R, Honculada CS, Houston P, Walters JL. Fully Synthetic Bioengineered Nanomedical Scaffold in Chronic Neuropathic Foot Ulcers. Wounds. 2018;30(10).

11) Price T. Use of a synthetic hybrid-scale fiber matrix in the management of chronic and complex wounds: a retrospective case series. Wounds. 2023;35(6):E197-E202. doi:10.25270/wnds/22091

12) Montminy T, Oppenheimer NE, Cocco D. Management of irradiated post-mastectomy wound dehiscence with synthetic electrospun fiber matrix: a case report. Front Oncol. 2024;14:1371122. Published 2024 Apr 18. doi:10.3389/fonc.2024.1371122

13) Harder JG, Hernandez EJ, MacEwan MM, et al. Histopathologic Analysis of a Recalcitrant Calcaneal Wound Treated Using a Synthetic Hybrid-scale Fiber Matrix. Plast Reconstr Surg Glob Open. 2024;12(2):e5597. Published 2024 Feb 6. doi:10.1097/GOX.0000000000005597

14) Herron K. Treatment of a Complex Pressure Ulcer Using a Synthetic Hybrid-Scale Fiber Matrix. Cureus. 2021;13(4):e14515. Published 2021 Apr 16. doi:10.7759/cureus.14515

15) Fernandez LG, Orsi C, Okeoke B, et al. Synergistic clinical application of synthetic electrospun fiber wound matrix in the management of a complex traumatic wound: degloving left groin and thigh auger injury. Wounds. 2024;36(4):124-128. doi:10.25270/wnds/23117

16) Fernandez L, Shar A, Matthews M, et al. Synthetic hybrid-scale fiber matrix in the trauma and acute care surgical practice. Wounds. 2021;33(9):237–244. doi:10.25270/wnds/2021.237244

17) Martini CJ, Burgess B, Ghodasra JH. Treatment of traumatic crush injury using a synthetic hybrid-scale fiber matrix in conjunction with split-thickness skin graft. Foot & Ankle Surgery: Techniques, Reports & Cases. 2022;2(1):100112. doi:10.1016/j.fastrc.2021.100112

18) Temple EW. Treatment of hematomas using a synthetic hybrid-scale fiber matrix. Cureus. 2022. doi:10.7759/cureus.26491

19) Fernandez LG, Matthews MR, Kim PJ. A synthetic hybrid-scale fiber matrix for complex surgical wounds: consensus guidelines. Wounds. 2023;35(5):E160-E168. doi:10.25270/wnds/22067

20) Chowdhry S. Utility of a Synthetic Hybrid-Scale Fiber Matrix in Surgical Soft Tissue Reconstruction. Eplasty. 2024;24:e2. Published 2024 Jan 4.

21) Lindeque B, Moon D. Wound healing outcomes following treatment with synthetic hybrid-scale fiber matrix after resection of soft tissue tumors or infections. Wounds. 2024;36(2):34-38. doi:10.25270/wnds/23091

22) Peter Horwich, Shanmugappiriya Sivarajah, David Neskey, Joshua Hornig; Applications of Synthetic Hybrid-Scale Fiber Matrix in Head and Neck Reconstruction: A Case Series. Case Rep Oncol 18 June 2024; 17 (1): 622–629. https://doi.org/10.1159/000539200.

23) McGowan J. Reconstruction of post-Mohs surgical wounds using a novel nanofiber matrix. Wounds. Published online July 18, 2022. doi:10.25270/wnds/20150

24) Zaiac M, Kauffman M, Matin T, Rosen J, Sallade E. Utility of synthetic hybrid-scale fiber matrix in dermatologic wounds. JAAD Case Rep. 2023;40:109-111. Published 2023 Aug 29. doi:10.1016/j.jdcr.2023.08.020

25) MacEwan MR, MacEwan S, Kovacs TR, Batts J. What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold. Cureus. 2017;9(10):e1736. Published 2017 Oct 2. doi:10.7759/cureus.1736

26) MacEwan MR, MacEwan S, Wright AP, Kovacs TR, Batts J, Zhang L. Comparison of a Fully Synthetic Electrospun Matrix to a Bi-Layered Xenograft in Healing Full Thickness Cutaneous Wounds in a Porcine Model. Cureus. 2017;9(8):e1614. Published 2017 Aug 27. doi:10.7759/cureus.1614

27) Hagen SS. Utility of synthetic electrospun fiber matrix in general sugery: From head to toe. Surgery. 2024; in press

28) Patel S. Application of abductor digiti minimi muscle flap and synthetic electrospun fiber matrix after resection of osteomyelitis of fifth metatarsal: A two-patient case report. Foot & Ankle Surgery: Techniques, Reports & Cases. Published online August 2024:100418. doi:10.1016/j.fastrc.2024.100418

Disclaimer: Restrata has not been studied in wounds that extend into the tendon, muscle, joint capsule, or bone. Please refer to the Product's Instructions for Use for a full list of indications, contraindications, precautions, and warnings.

Contact a surgical account executive today!

Get Started

or call (844) 879-2237

Revolutionizing Healing. Changing Lives.

•

Cerafix®, Covora®, and Restrata® are registered trademarks of Acera Surgical Inc.

•

Privacy & Security

This website, Acera-Surgical.com, is owned and operated by Acera Surgical. We are strongly committed to protecting the privacy of our website users. The intent of our privacy policy is to inform you, the user, about the information that we may collect about visitors to our site, how we use that information, and about our disclosure practices.

Acera Surgical is committed to high standards that require honesty, integrity and fairness. Acera Surgical will collect no personal information about you unless you choose to provide that information to us. We do not use techniques that collect personal information about you without your knowledge. You have the right to decline to have any information collected or transferred for marketing purposes.

What Happens To Your Personal Information?

All personal information that is collected on our website is stored in a secure location. At no time will Acera Surgical solicit personal information to third party vendors without prior consent, as we respect the privacy and confidentiality of our website visitors.

What About Spam?

Subscribers will not receive any unsolicited emails or correspondence if they have not provided Acera Surgical with prior permission. From time to time, we may use email as a way to keep in touch with our website visitors; however, we do not send “spam” (unsolicited marketing email). If you agree to receive email communications from us, every email message we send to you will include an email address to which you can respond. If at any time you decide you do not want to receive marketing email from us, simply let us know and we will remove your name and email address from our mailing list.

When You Leave This Site

This policy discloses the privacy practices for our website. However, our site contains links to other sites. Once you link to another site, you are subject to the privacy and security policies of the new site. We encourage you to read the privacy policies of all websites you visit, especially if you share any personal information.

Security Policy

Users are prohibited from violating or attempting to violate the security of the site. By way of example, you are prohibited from (a) accessing data not intended for such user or logging onto a server or an account which the user is not authorized to access; (b) attempting to probe, scan or test the vulnerability of a system or network or to breach security without proper authorization; (c) attempting to interfere with service to any user, host or network; (d) sending unsolicited mail, including promotions and/or advertising of products or services.

Clinical Compendium

The body of published clinical data on Restrata continues to grow.

A New Standard in Clinical Results

Summary of Select PublicationsSelect a disease state below for the list of publications

Contact a surgical account executive today!

Privacy & Security

What Happens To Your Personal Information?

What About Spam?

When You Leave This Site

Security Policy

Summary of Select Publications
Select a disease state below for the list of publications